U.S. Food and Drug Administration Seeks Comments for Scheduling Cannabis Under International Agreements
On Monday, April 9, 2018, the U.S. Food and Drug Administration (“FDA”) published a notice in the Federal Register seeking public comment from interested persons on the scheduling status of cannabis, under international agreements, in a number of forms, including cannabis extracts, THC and CBD. FDA is seeking comments on cannabis to inform the Agency’s final testimony for the World Health Organization (“WHO”) later this year. WHO’s Expert Committee on Drug Dependence will use FDA’s testimony to aid in WHO’s analysis of the current status of cannabis on its potential to cause dependence, abuse and harm to health, as well as its medical and therapeutic uses. WHO will then make recommendations to the United Nations on whether there is a need for international control of these substances.
FDA is accepting comments through April 23, 2018, and all interested persons, including hemp and marijuana businesses, have an opportunity to contribute to the Agency’s cannabis analysis. The Firm’s clients are encouraged to submit comments in an effort to change the scheduling status of cannabis and highlight the medical and therapeutic benefits of cannabis derived treatments. Commenters on this matter will also be able to challenge any FDA rule governing cannabis that may stem from this process. McAllister Garfield has extensive experience participating in agency rulemaking and is happy to submit comments on behalf of clients. Time is of the essence in this matter, so do not hesitate to contact the Firm so that we may begin drafting comments on behalf of your entity.
Related Article

August 2025 Psychedelic Law Update
Status of Colorado Model State Screening Forms For many months, DORA has been promising to release the model screening forms that will satisfy the requirements of the Natural Medicine Health Act to conduct a psilocybin healing administration session under the state regulated program. However, the models forms have not yet been finalized or released. There […]

July 2025 Psychedelic Law Update
Denver Local Natural Medicine Licenses Now Available The City of Denver is requiring a local license fornatural medicine healing centers that allow original facilitators to practice as a result of Denver City Council unanimously approvingCouncil Bill 25-0132in March. Healing centers with only clinical facilitators are exempt from the local licensing requirements. Natural medicine cultivating, manufacturing […]

June 2025 Psychedelic Law Update
NMHA System is Live with Licensing of Testing Facility – Medicine available With the licensing of the first testing facility in Colorado, the regulated natural medicine supply chain is complete and the program is fully launched for operations. The state issued a compliance tip guidance on testing. See the guidance here. McAllister Law has a list […]